Bronchodilator response in the lung health study over 11 yrs
Open Access
- 1 July 2005
- journal article
- research article
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 26 (1) , 45-51
- https://doi.org/10.1183/09031936.05.00102604
Abstract
Long-term changes in bronchodilator response in people with mild chronic obstructive pulmonary disease were assessed in this study.Changes in forced expiratory volume in one second (FEV1) in response to isoproterenol was measured in 4,194 participants in the Lung Health Study annually for 5 yrs, and again 11 yrs after study entry. Responses were quantitated in terms of mL (absolute), as per cent of the pre-bronchodilator value (relative), and as a per cent of the predicted normal value (% predicted).At baseline, the mean pre-bronchodilator FEV1was 75.4% predicted, and responses were small. Relative and percentage predicted responses were similar in males and females; and correlated positively with methacholine reactivity, and negatively with smoking intensity and age. Baseline bronchodilator responses did not correlate with subsequent decline in FEV1. There was a substantial increase in response over the first year of the study, largely due to smoking cessation, with larger increases in those who stopped smoking. After the first year absolute responses changed little in those who maintained smoking cessation, but increased in those who did not. Mean relative and percentage predicted responses increased in all participants throughout the study. There was substantial annual variability of absolute response, and it was poorly reproducible in individual participants.In conclusion, smoking cessation increased bronchodilator response, and response did not predict the rate of decline of forced expiratory volume in one second.Keywords
This publication has 13 references indexed in Scilit:
- Bronchodilator reversibility testing in chronic obstructive pulmonary diseaseThorax, 2003
- Canadian Thoracic Society Recommendations for Management of Chronic Obstructive Pulmonary Disease – 2003Canadian Respiratory Journal, 2003
- Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2001
- Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trialBMJ, 2000
- Long-Term Treatment with Inhaled Budesonide in Persons with Mild Chronic Obstructive Pulmonary Disease Who Continue SmokingNew England Journal of Medicine, 1999
- Effect of Weight Gain on Pulmonary Function after Smoking Cessation in the Lung Health StudyAmerican Journal of Respiratory and Critical Care Medicine, 1998
- Effects of Smoking Intervention and the Use of an Inhaled Anticholinergic Bronchodilator on the Rate of Decline of FEV1JAMA, 1994
- Gender difference in airway hyperresponsiveness in smokers with mild COPD. The Lung Health Study.American Journal of Respiratory and Critical Care Medicine, 1994
- The Lung Health Study: Airway Responsiveness to Inhaled Methacholine in Smokers with Mild to Moderate Airflow LimitationAmerican Review of Respiratory Disease, 1992
- Spirometry in the Lung Health Study: 1. Methods and Quality ControlAmerican Review of Respiratory Disease, 1991